- APRE 19/07/2016
IMMUTRAIN – Immunotherapy of cancer is a research training network funded by the Marie Sklodowska-Curie Actions.
It comprises nine academic research groups and five industrial partners in nine European countries. The joint goal is to train the next generation of scientists in the field of immunotherapy of cancer. The research objective of IMMUTRAIN is to enhance the efficacy of antibody-based tumor therapies through combination with other immunotherapeutic approaches.
Open positions: Munich, Germany, Division of Clinical Pharmacology, Ludwig-Maximilians-Universitaet: ESR 1, ESR 13
The projects should start from September and not later than November 2016 for a period of three years.
The application procedure will be carried out in compliance with the Code of Conduct for Recruitment and the Charter for Researchers.
|Quadro di finanziamento||
|Area di interesse||
|Tipo di finanziamento||